Radiculopathy is produced by the pinching of a nerve root in the spinal column. The problem occurs near a specific nerve; however, pain and associated symptoms usually appear in the part of the body where that specific nerve is supplied. For example, a nerve impingement in the lumbar region can be manifested with symptoms in the foot. Similarly, an impingement in the cervical spine could result in pain and associated symptoms in the forearm. The most common symptoms include pain (known as radicular pain), numbness or parasthesia, weakness in limbs, and difficulty in controlling specific muscles. It can develop at any age; however, most of radiculopathy cases have been recorded in people aged between 45 and 64. Women are at higher risk of developing radiculopathy than men. People suffering from degenerative diseases, any kind of infection, diabetes, or who are engaged in heavy lifting or high-impact sports or suffering from the conditions such as spurs, disc herniation, or scoliosis are at higher risk of developing radiculopathy.
The global radiculopathy market can be segmented based on type, treatment, and region. In terms of type, the global market can be categorized into lumbar radiculopathy (affects lower neck), cervical radiculopathy (compressed nerve root in the neck), and thoracic radiculopathy (compressed nerve root in the thoracic area of the spine). The lumbar radiculopathy segment is expected to be driven by high incidence rate. In terms of treatment, the global radiculopathy market can be classified into conservative treatment, epidural steroid injection, and surgical treatment. Conservative treatment includes medicines such as non-steroidal anti-inflammatory drugs, opioid medicines, and muscle relaxants. Conservative treatment is used to manage pain, muscle spasm, inflammation, and sleep disturbance. Cervical posterior foraminotomy is commonly performed surgery for radiculopathy; however, other surgeries are also available. Rise in incidence and prevalence rates of radiculopathy, increased research and development expenditure, surge in awareness among people are likely to contribute to the growth of the global radiculopathy market during the forecast period. However, poor patient awareness and increase in use of home remedies hamper the growth of the market.
Geographically, the global radiculopathy market can be segmented into five major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the global market, followed by Europe. An estimated 3% to 5% of the population of the U.S. is affected by radiculopathy. Hence, increase in incidence rate boosts the growth of the market in North America. Additionally, growing awareness among people, increase in research and development expenditure, and well-established health care infrastructure fuel the growth of the radiculopathy market in North America. The market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. The market is driven by large population base, increased government initiatives, and developing health care infrastructure in India and China. The market in Latin America and Middle East & Africa is anticipated to be driven by increase in investments by key players and rise in prevalence of radiculopathy.
Leading players in the global radiculopathy market include DePuy Synthes, Inc. (Johnson & Johnson Company), Bayer AG, and Biogen Idec.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.